Viewing data from:

CLONAZEPAM

ANDA

CLONAZEPAM | A077171 | PH HEALTH LTD

5 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 5 NDCs

Highest NADAC/Unit

$0.8510

per ea

Lowest NADAC/Unit

$0.4744

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
49884031002CLONAZEPAM 2 MG ODT	$0.8510	EA	Generic	—	2026-06-17
49884030902CLONAZEPAM 1 MG DIS TABLET	$0.5634	EA	Generic	—	2026-06-17
49884030602CLONAZEPAM 0.125 MG DIS TAB	$0.5417	EA	Generic	—	2026-06-17
49884030802CLONAZEPAM 0.5 MG DIS TABLET	$0.4994	EA	Generic	—	2026-06-17
49884030702CLONAZEPAM 0.25 MG ODT	$0.4744	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 5 NDCs (5 FSS)

Lowest Price

$54.83

Highest Price

$87.11

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
49884-0306-02CLONAZEPAM 0.125MG TAB,ORALLY DISINTEGRATING	$54.92	FSS	Golden State Medical Supply, Inc.	06/14/2028
49884-0307-02CLONAZEPAM 0.25MG TAB,ORALLY DISINTEGRATING	$54.92	FSS	Golden State Medical Supply, Inc.	06/14/2028
49884-0308-02CLONAZEPAM 0.5MG TAB,ORALLY DISINTEGRATING	$54.83	FSS	Golden State Medical Supply, Inc.	06/14/2028
49884-0309-02CLONAZEPAM 1MG TAB,ORALLY DISINTEGRATING	$62.73	FSS	Golden State Medical Supply, Inc.	06/14/2028
49884-0310-02CLONAZEPAM 2MG TAB,ORALLY DISINTEGRATING	$87.11	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain7 active DMFs4 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

FIS FABBRICA ITALIANA SINTETICI SPACLONAZEPAM

DMF 75051988

CAMBREX PROFARMACO MILANO SRLCLONAZEPAM

DMF 113511995

PH HEALTH LTDCLONAZEPAM

DMF 162452002

SUN PHARMACEUTICAL INDUSTRIES LTDCLONAZEPAM USP

DMF 177272004

APOTEX PHARMACHEM INDIA PVT LTDCLONAZEPAM USP

DMF 221672008

CENTAUR PHARMACEUTICALS PVT LTDCLONAZEPAM USP

DMF 225802009

R L FINE CHEM PVT LTDCLONAZEPAM

DMF 380702023

DIOSYNTH BVInactiveCLONAZEPAM

DMF 86781990

HOECHST CELANESE CORPInactiveCLONAZEPAM

DMF 118971996

ZHEJIANG HISUN PHARMACEUTICAL CO LTDInactiveCLONAZEPAM, USP

DMF 129861998

LAKE CHEMICALS PRIVATE LTDInactiveCLONAZEPAM

DMF 225832009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Dec 24, 2009	SUPPL -6	View Letter (PDF)
Aug 8, 2005	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.